Reporter Dec 13 2019
Cell fate signaling
Dec. 17, 2019—A newly identified protein interaction that affects cell cycle regulation may be an attractive target for cancer therapy.
Protein dynamics in the beating heart
Dec. 16, 2019—To study the dynamics of structural proteins in the heart, Vanderbilt investigators generated a cellular tool they expect will be useful for screening drugs that affect heart muscle contraction.
The American College of Medical Genetics and Genomics advises evaluating all breast cancer patients to determine the need for genetic testing
Dec. 13, 2019—According to a statement on behalf of the American College of Medical Genetics and Genomics, there is insufficient evidence to recommend universal genetic testing for BRCA1/2 alone or in combination with multi-gene panels for all breast cancer patients.
Vanderbilt reports record $11.9 billion economic impact in Tennessee
Dec. 12, 2019—Through a record $11.9 billion in annual economic impact, Vanderbilt University’s deep and broad connections to Tennessee and its people continue to be key and growing drivers of the state’s economy and to the vitality and well-being of its citizens and communities.
New training materials help clinicians stay opioid compliant
Dec. 12, 2019—Vanderbilt University Medical Center, through the offices of its Opioid Oversight Executive Committee, is offering its employees an online tutorial, Opioid Laws — Prescribing at VUMC
VUMC-led team isolates antibody that blocks bird flu
Dec. 12, 2019—VUMC scientists are redoubling their efforts to help people fight off bird flu. Their focus is H7N9, one of the most dangerous of the influenza viruses that have been transmitted from birds to humans.
A new anti-seizure target?
Dec. 12, 2019—Vanderbilt neurologists have identified a protein modification that could be targeted to reduce neuronal excitability in epilepsy.
Study explores burnout among APRNs, physician assistants
Dec. 12, 2019—In one of the first studies to document burnout among advanced practice registered nurses (APRNs) and physician assistants (PAs), Vanderbilt researchers examined causes and solutions.
Study examines HIV drug’s potential to treat Alzheimer’s
Dec. 12, 2019—A drug used to treat and prevent HIV/AIDS is showing promise as a potential therapy for Alzheimer’s disease.
New tool may speed antibody, vaccine research
Dec. 12, 2019— by Allison Whitten The antibody discovery and vaccine development research fields may be on the verge of rapidly expanding with data that previously took decades to acquire, thanks to LIBRA-seq, a new tool developed by Vanderbilt University researchers and their colleagues. Currently, due to technological constraints, it can take up to a year to...
Diabetes Day shines spotlight on crucial research
Dec. 12, 2019—Research in the fields of diabetes, endocrinology and metabolism were highlighted recently during the annual Diabetes Day at the Vanderbilt Student Life Center.
Gore named to committee on worker health overseas
Dec. 12, 2019—John Gore, PhD, has been appointed to a National Academies of Sciences, Engineering and Medicine standing committee to advise the Department of State on unexplained health effects on U.S. government employees and their families at overseas embassies.
